Dr. Kabu Chawla, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 953 49th St, Suite 511, Brooklyn, NY 11219 Phone: 718-283-8380 Fax: 718-283-7884 |
Sophia S Kwon, DO Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 150 55th St, Brooklyn, NY 11220 Phone: 718-630-7000 Fax: 718-630-8515 |
Dr. Rattan Mahendrakumar Patel, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 9602 4th Ave Apt 4l, Brooklyn, NY 11209 Phone: 718-680-0657 |
Mediha Ibrahim, M.D Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 Clarkson Ave, Brooklyn, NY 11203 Phone: 718-836-6600 |
Dr. Ravindra M. Mehta, M.D. Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 800 Poly Pl, Medical Service (111), Brooklyn, NY 11209 Phone: 718-630-3722 Fax: 718-630-2889 |
News Archive
Researchers at the University of Leicester and Meningococcal Reference Unit have developed a new approach to assess the effectiveness of the Men B vaccine, Bexsero, against different strains that cause meningococcal meningitis and septicaemia.
Flynas, an award winning leading low cost airline of Saudi Arabia has set new standards to in-flight safety, by adding Virus Guard disinfectant wet wipes and sprays to its in-flight hygiene, to protect passengers from viruses such as MERS, Birdflu.
Biomaterials and medical devices must be rigorously tested in the laboratory before they may be implanted into test subjects. By ensuring that these test methods are both quick and efficient, an increased number of materials can be tested and working implants can be produced more rapidly. The development of such tests is therefore essential to biomedical advancement, and Characterization of biomaterials reviews the latest methods for defining properties and characterizing materials. Characterization of biomaterials discusses a wide array of techniques and various unique approaches to the problems faced in characterizing biomaterials, whilst also providing information on standards and methods for assessing the safety and biocompatibility of biomaterials.
In a recent study, scientists from the Institute for Cancer Research at MedUni Vienna have shown that the growth factor receptor FGFR3 increases the rate of growth and aggressiveness of hepatocellular carcinomas (liver cell cancer). Inhibition of this receptor could be a new and effective way of treating patients.
The introduction of methicillin into clinical practice is not what caused the emergence of methicillin resistant Staphylococcus aureus (MRSA), report researchers. According to a collaborative study by the University of St Andrews, University of Dundee and the Wellcome Trust Sanger Institute, MRSA existed long before clinicians started using the antibiotic.
› Verified 5 days ago